Cargando…

Adenosine A(3) Receptor (A(3)AR) Agonist for the Treatment of Bleomycin-Induced Lung Fibrosis in Mice

Adenosine receptors (ARs) are involved in the suppression and development of inflammatory and fibrotic conditions. Specifically, AR activation promotes differentiation of lung fibroblasts into myofibroblasts, typical of a fibrotic event. Pulmonary fibrosis is a severe disease characterized by inflam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sgambellone, Silvia, Marri, Silvia, Catarinicchia, Stefano, Pini, Alessandro, Tosh, Dilip K., Jacobson, Kenneth A., Masini, Emanuela, Salvemini, Daniela, Lucarini, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657240/ https://www.ncbi.nlm.nih.gov/pubmed/36362112 http://dx.doi.org/10.3390/ijms232113300

Ejemplares similares

New Insight in Histamine Functions
por: Sgambellone, Silvia, et al.
Publicado: (2022)

The Histamine H(4) Receptor Participates in the Anti-Neuropathic Effect of the Adenosine A(3) Receptor Agonist IB-MECA: Role of CD4(+) T Cells
por: Micheli, Laura, et al.
Publicado: (2021)

Role of Histamine H(3) Receptor Antagonists on Intraocular Pressure Reduction in Rabbit Models of Transient Ocular Hypertension and Glaucoma
por: Lanzi, Cecilia, et al.
Publicado: (2019)

Structural Probing of Off-Target G Protein-Coupled Receptor Activities within a Series of Adenosine/Adenine Congeners
por: Paoletta, Silvia, et al.
Publicado: (2014)

Effects of PARP-1 Deficiency and Histamine H(4) Receptor Inhibition in an Inflammatory Model of Lung Fibrosis in Mice
por: Durante, Mariaconcetta, et al.
Publicado: (2019)

In Vivo Phenotypic Screening for Treating Chronic Neuropathic Pain: Modification of C2-Arylethynyl Group of Conformationally Constrained A(3) Adenosine Receptor Agonists
por: Tosh, Dilip K., et al.
Publicado: (2014)

Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A(3) Adenosine Receptor Agonists
por: Tosh, Dilip K., et al.
Publicado: (2016)

Role of histamine H(4) receptor in the anti-inflammatory pathway of glucocorticoid-induced leucin zipper (GILZ) in a model of lung fibrosis
por: Sgambellone, Silvia, et al.
Publicado: (2023)

Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
por: Jacobson, Kenneth A., et al.
Publicado: (2019)

Novel Insight of Histamine and Its Receptor Ligands in Glaucoma and Retina Neuroprotection
por: Sgambellone, Silvia, et al.
Publicado: (2021)

Targeting the A(3) adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice
por: Singh, Anand Kumar, et al.
Publicado: (2022)

NCX 470 Exerts Retinal Cell Protection and Enhances Ophthalmic Artery Blood Flow After Ischemia/Reperfusion Injury of Optic Nerve Head and Retina
por: Sgambellone, Silvia, et al.
Publicado: (2023)

HYDAMTIQ, a selective PARP‐1 inhibitor, improves bleomycin‐induced lung fibrosis by dampening the TGF‐β/SMAD signalling pathway
por: Lucarini, Laura, et al.
Publicado: (2016)

Effects of New NSAID-CAI Hybrid Compounds in Inflammation and Lung Fibrosis
por: Lucarini, Laura, et al.
Publicado: (2020)

Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A(3) Receptor Subtype
por: Coppi, Elisabetta, et al.
Publicado: (2021)

The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A(3) Receptor Agonist, in a Rat Model of Colitis
por: Antonioli, Luca, et al.
Publicado: (2020)

D-Tagatose Feeding Reduces the Risk of Sugar-Induced Exacerbation of Myocardial I/R Injury When Compared to Its Isomer Fructose
por: Durante, Mariaconcetta, et al.
Publicado: (2021)

Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
por: Tosh, Dilip K., et al.
Publicado: (2018)

John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors()
por: Jacobson, Kenneth A., et al.
Publicado: (2014)

Structural Probing and Molecular Modeling of the A(3) Adenosine Receptor: A Focus on Agonist Binding
por: Ciancetta, Antonella, et al.
Publicado: (2017)

Polyamidoamine (PAMAM) dendrimer conjugate specifically activates the A(3 )adenosine receptor to improve post-ischemic/reperfusion function in isolated mouse hearts
por: Wan, Tina C, et al.
Publicado: (2011)

Adenosine Metabotropic Receptors in Chronic Pain Management
por: Luongo, Livio, et al.
Publicado: (2021)

Sulfonamide Inhibitors of Human Carbonic Anhydrases Designed through a Three-Tails Approach: Improving Ligand/Isoform Matching and Selectivity of Action
por: Bonardi, Alessandro, et al.
Publicado: (2020)

Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose
por: Collotta, Debora, et al.
Publicado: (2018)

Flexible modulation of agonist efficacy at the human A(3 )adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000
por: Gao, Zhan-Guo, et al.
Publicado: (2008)

Poly(ADP-ribose) polymerase inhibition with HYDAMTIQ reduces allergen-induced asthma-like reaction, bronchial hyper-reactivity and airway remodelling
por: Lucarini, Laura, et al.
Publicado: (2014)

Species dependence of A(3) adenosine receptor pharmacology and function
por: Gao, Zhan-Guo, et al.
Publicado: (2022)

The “C3aR Antagonist” SB290157 is a Partial C5aR2 Agonist
por: Li, Xaria X., et al.
Publicado: (2021)

3′5-Dimaleamylbenzoic Acid Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: González-García, Karina, et al.
Publicado: (2022)

Immune Mechanisms of Pulmonary Fibrosis with Bleomycin
por: Ishida, Yuko, et al.
Publicado: (2023)

Adenosine-Related Mechanisms in Non-Adenosine Receptor Drugs
por: Jacobson, Kenneth A., et al.
Publicado: (2020)

Synthesis and Anti-Renal Fibrosis Activity of Conformationally Locked Truncated 2-Hexynyl-N(6)-Substituted-(N)-Methanocarba-nucleosides as A(3) Adenosine Receptor Antagonists and Partial Agonists
por: Nayak, Akshata, et al.
Publicado: (2014)

Asiaticoside might attenuate bleomycin‐induced pulmonary fibrosis by activating cAMP and Rap1 signalling pathway assisted by A2AR
por: Luo, Jing, et al.
Publicado: (2020)

Alpha-Mangostin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice Partly Through Activating Adenosine 5′-Monophosphate-Activated Protein Kinase
por: Li, Ren-shi, et al.
Publicado: (2019)

Acute exacerbation of idiopathic pulmonary fibrosis model in the rats using bleomycin and lipopolysaccharides
por: Kurniawan, Sandy Vitria, et al.
Publicado: (2023)

Inhibiting Skp2 E3 Ligase Suppresses Bleomycin-Induced Pulmonary Fibrosis
por: Mikamo, Masashi, et al.
Publicado: (2018)

L-plastin enhances NLRP3 inflammasome assembly and bleomycin-induced lung fibrosis
por: Joshi, Hemant, et al.
Publicado: (2022)

Adenosine A(3) receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury
por: Farr, Susan A., et al.
Publicado: (2020)

Convergent synthesis of 2-thioether-substituted (N)-methanocarba-adenosines as purine receptor agonists
por: Suresh, R. Rama, et al.
Publicado: (2021)

Optical Control of Adenosine A(3) Receptor Signaling: Towards a Multimodal Phototherapy in Psoriasis?
por: Ciruela, Francisco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q3gu4m0q66dbc6sngke1hu6ssn